The inactivation of human C1 by benzamidine and pyridinium sulfonylfluorides
Bing, D.H.; Cory, M.; Doll, M.
Journal of Immunology 113(2): 584-590
1974
ISSN/ISBN: 0022-1767 PMID: 4845666 Document Number: 76723
Document emailed within 1 workday
Related Documents
Pernak, J.; Krysiński, J.; Kuncewicz, Z. 1984: Effect of new quaternary pyridinium compounds against selected bacterial and fungal strains. 12. Synthesis of 4-ethyl-1-(n-alkylthiomethyl)- and 4-ethyl-1-(n-alkoxymethyl)pyridinium chlorides Die Pharmazie 39(11): 782-783Morganti, A.; Sala, C.; Turolo, L.; Auxilia, F.; Cianci, L.; Checchini, M.; Zanchetti, A. 1987: Effectiveness of Sepharose-bound trypsin versus liquid-phase trypsin plus benzamidine for activation of inactive renin in human plasma Journal of Laboratory and Clinical Medicine 109(1): 13-18
Maier, M.; Spragg, J.; Schwartz, L.B. 1983: Inactivation of human high molecular weight kininogen by human mast cell tryptase Journal of Immunology 130(5): 2352-2356
Rosengard, A.M.; Cary, N.; Horsley, J.; Belcher, C.; Langford, G.; Cozzi, E.; Wallwork, J.; White, D.J. 1995: Endothelial expression of human decay accelerating factor in transgenic pig tissue: a potential approach for human complement inactivation in discordant xenografts Transplantation Proceedings 27(1): 326-327
Budovskiĭ, E.I.; Zalesskaia, M.A. 1985: Principles of selective inactivation of the viral genome. III. Kinetics of the inactivation of bacteriophage MS2 infectivity by beta-propiolactone Molekuliarnaia Biologiia 19(4): 1139-1147
Hackemann, M.M.; Denman, A.M.; Tyrrell, D.A. 1974: Inactivation of influenza virus by human lymphocytes Clinical and Experimental Immunology 16(4): 583-591
Hauptmann, J. 1982: Pharmacology of benzamidine-type thrombin inhibitors Folia Haematologica 109(1): 89-97
Walsmann, P. 1977: Inhibition of serine proteinases by benzamidine derivatives Acta Biologica et Medica Germanica 36(11-12): 1931-1937
Stürzebecher, J.; Prasa, D.; Wikström, P.; Vieweg, H. 1994: Novel plasma kallikrein inhibitors of the benzamidine type Brazilian Journal of Medical and Biological Research 27(8): 1929-1934
Polsky, B.; Segal, S.J.; Baron, P.A.; Gold, J.W.; Ueno, H.; Armstrong, D. 1989: Inactivation of human immunodeficiency virus in vitro by gossypol Contraception 39(6): 579-587
Vzorov, A.N.; Dixon, D.W.; Trommel, J.S.; Marzilli, L.G.; Compans, R.W. 2002: Inactivation of human immunodeficiency virus type 1 by porphyrins Antimicrobial Agents and Chemotherapy 46(12): 3917-3925
Shimada, T.; Guengerich, F.P. 1990: Inactivation of 1,3-, 1,6-, and 1,8-dinitropyrene by cytochrome P-450 enzymes in human and rat liver microsomes Cancer Research 50(7): 2036-2043
Fazi, A.; Mancini, U.; Piatti, E.; Accorsi, A.; Magnani, M. 1991: Human red blood cells as bioreactors for the inactivation of harmful xenobiotics Biotechnology and Applied Biochemistry 14(1): 60-68
Sebti, S.M.; Jani, J.P.; Mistry, J.S.; Gorelik, E.; Lazo, J.S. 1991: Metabolic inactivation: a mechanism of human tumor resistance to bleomycin Cancer Research 51(1): 227-232
Reed, D.J.; Lin, X.; Thomas, T.D.; Birks, C.W.; Tang, J.; Rother, R.P. 1997: Alteration of glycosylation renders HIV sensitive to inactivation by normal human serum Journal of Immunology 159(9): 4356-4361
Koudriakova, T.; Iatsimirskaia, E.; Utkin, I.; Gangl, E.; Vouros, P.; Storozhuk, E.; Orza, D.; Marinina, J.; Gerber, N. 1998: Metabolism of the human immunodeficiency virus protease inhibitors indinavir and ritonavir by human intestinal microsomes and expressed cytochrome P4503A4/3A5: mechanism-based inactivation of cytochrome P4503A by ritonavir Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(6): 552-561
Mauler, R.; Merkle, W.; Hilfenhaus, J. 1987: Inactivation of HTLV-III/LAV, hepatitis B and non-A/non-B viruses by pasteurization in human plasma protein preparations Developments in Biological Standardization 67: 337-351
Shapshak, P.; McCoy, C.B.; Rivers, J.E.; Chitwood, D.D.; Mash, D.C.; Weatherby, N.L.; Inciardi, J.A.; Shah, S.M.; Brown, B.S. 1993: Inactivation of human immunodeficiency virus-1 at short time intervals using undiluted bleach Journal of Acquired Immune Deficiency Syndromes 6(2): 218-219
Erdös, E.G.; Johnson, A.R.; Boyden, N.T. 1978: Inactivation of enkephalins: effect of purified peptidyl dipeptidase and cultured human endothelial cells Advances in Biochemical Psychopharmacology 18: 45-49
Shibata, T.; Ogawa, M.; Takata, N.; Matsuda, K.; Niinobu, T.; Uda, K.; Wakasugi, C.; Mori, T. 1987: Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa Research Communications in Chemical Pathology and Pharmacology 55(2): 243-248